Table 5.
Neonatal outcomes in the PE-like group vs the PE and non-PE groups
| Variables | PE like (n=8) | PE (n=7+1) | Non-PE (n=53+2) |
|---|---|---|---|
| Delivery | |||
| Vaginal | 3/8 (37.5)a | 0/7 (0) | 34/52 (65.4) |
| Vaginal assisted | 2/8 (25.0)a | 0/7 (0) | 3/52 (5.8) |
| Cesarean delivery | 3/8 (37.5)a | 7/7 (100.0) | 15/52 (28.9) |
| Gestational age at delivery | 39.1 (38.2–40.7)a | 36.3 (32.0–36.8) | 39 (37.9–40.0) |
| Born alive | 8/8 (100.0) | 8/8 (100.0) | 55/55 (100.0) |
| Birthweight (g) | 2737.5 (2637.3–3037.5)a | 2412.5 (1683.8–2580.0) | 3130.0 (2900.0–3540.0) |
| Apgar score of <7 at 5 min | 0/8 (0) | 2/8 (25.0) | 0/50 (0) |
| Arterial pH<7 | 0/7 (0) | 0/8 (0) | 1/21 (4.8) |
| Hypoglycemia | 0/8 (0) | 0/8 (0) | 0/41 (0) |
| Jaundice with phototherapy | 0/8 (0) | 1/8 (12.5) | 1/41 (2.4) |
| Intraventricular hemorrhage | 0/8 (0) | 0/8 (0) | 0/49 (0) |
| Necrotizing enterocolitis | 0/8 (0) | 0/8 (0) | 0/49 (0) |
| Sepsis | 0/8 (0) | 0/8 (0) | 0/49 (0) |
| Seizures | 0/8 (0) | 0/8 (0) | 0/49 (0) |
| Respiratory distress syndrome | 0/8 (0) | 3/8 (37.5) | 1/48 (2.0) |
| Periventricular leukomalacia | 0/8 (0) | 0/8 (0) | 0/49 (0) |
| Composite adverse neonatal outcomes | 0/8 (0) | 3/8 (37.50) | 2/55 (3.64) |
Continuous data are presented as median (interquartile range). Categorical data are presented as frequency (percentage).
PE, preeclampsia.
a
Statistically significant difference compared to the preeclampsia group.
Serrano. Preeclampsia-like syndrome in severe COVID-19. Am J Obstet Gynecol MFM 2022.